Add 2137.HK to watchlist(s)

You Should Create a Watchlist In The First Place.

Profile

Company Name

Brii Biosciences Limited

Symbol

2137.HK

Currency

HKD

Exchange

HKSE

Head Quarter

China, Beijing

Sector

Healthcare

Industry

Biotechnology

Website

https://www.briibio.com

ISIN

KYG1645A1094

CIK

None

CUSIP

UEI

LEI

Business Description

Brii Biosciences Limited engages in the development of medicines for the treatment of infectious and central nervous system diseases. The company develops BRII-778 and BRII-732, which are in phase I clinical trials for the treatment of HIV patients; BRII-179 and BRII-835, which are in Phase 2 to evaluate the combination of these two HBV mechanisms for Hepatitis B; BRII-179, a recombinant protein-based HBV immunotherapeutic candidate that is in Phase 1b/2a;